Edward L. Brown

1.6k total citations
10 papers, 754 citations indexed

About

Edward L. Brown is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Edward L. Brown has authored 10 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 3 papers in Epidemiology. Recurrent topics in Edward L. Brown's work include Viral Infections and Immunology Research (7 papers), RNA and protein synthesis mechanisms (4 papers) and interferon and immune responses (2 papers). Edward L. Brown is often cited by papers focused on Viral Infections and Immunology Research (7 papers), RNA and protein synthesis mechanisms (4 papers) and interferon and immune responses (2 papers). Edward L. Brown collaborates with scholars based in United States. Edward L. Brown's co-authors include Shella A. Fuhrman, Rose Ann Ferre, Amy K. Patick, David A. Matthews, Stephen T. Worland, James W. Meador, Thomas F. Hendrickson, Susan L. Binford, Peter S. Dragovich and Ru Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Edward L. Brown

9 papers receiving 739 citations

Peers

Countries citing papers authored by Edward L. Brown

Since Specialization

Citations

This map shows the geographic impact of Edward L. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward L. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward L. Brown more than expected).

Fields of papers citing papers by Edward L. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward L. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward L. Brown. The network helps show where Edward L. Brown may publish in the future.

Co-authorship network of co-authors of Edward L. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Edward L. Brown. A scholar is included among the top collaborators of Edward L. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward L. Brown. Edward L. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Escitalopram-Associated Drug Rash 2025 ·Journal of Clinical Psychopharmacology ·Edward L. Brown, Fabiano G. Nery, (unknown), (unknown)	0
2	Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. Part 7: Structure–Activity Studies of Bicyclic 2-Pyridone-Containing Peptidomimetics 2002 ·Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Theodore Johnson, Edward L. Brown, (unknown), Shella A. Fuhrman, L S Zalman, Amy K. Patick, David A. Matthews, Xinjun Hou, James W. Meador, Rose Ann Ferre, Stephen T. Worland	63
3	Structure-Based Design of a Parallel Synthetic Array Directed Toward the Discovery of Irreversible Inhibitors of Human Rhinovirus 3C Protease 2002 ·Journal of Medicinal Chemistry ·Theodore Johnson, Hua Ye, (unknown), Edward L. Brown, (unknown), (unknown), Peter S. Dragovich, Brian Eastman, Rose Ann Ferre, Shella A. Fuhrman, Thomas F. Hendrickson, (unknown), David A. Matthews, James W. Meador, Amy K. Patick, Siegfried Reich, Donald J. Skalitzky, Stephen T. Worland, (unknown), L S Zalman	26
4	Substituted Benzamide Inhibitors of Human Rhinovirus 3C Protease: Structure-Based Design, Synthesis, and Biological Evaluation 2000 ·Journal of Medicinal Chemistry ·Siegfried Reich, Theodore Johnson, Michael B. Wallace, Susan E. Kephart, Shella A. Fuhrman, Stephen T. Worland, David A. Matthews, Thomas F. Hendrickson, (unknown), James W. Meador, Rose Ann Ferre, Edward L. Brown, Dorothy M. DeLisle, Amy K. Patick, Susan L. Binford, Clifford E. Ford	40
5	Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors 2000 ·Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich, Ru Zhou, Stephen E. Webber, Thomas J. Prins, Annette K. Kwok, Kōji Okano, Shella A. Fuhrman, L S Zalman, (unknown), Edward L. Brown, James W. Meador, Amy K. Patick, Clifford E. Ford, Mary A. Brothers, Susan L. Binford, David A. Matthews, Rose Ann Ferre, Stephen T. Worland	32
6	Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids 1999 ·Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich, Stephen E. Webber, Thomas J. Prins, Ru Zhou, Joseph Marakovits, Jayashree Tikhe, Shella A. Fuhrman, Amy K. Patick, David A. Matthews, Clifford E. Ford, Edward L. Brown, Susan L. Binford, James W. Meador, Rose Ann Ferre, Stephen T. Worland	18
7	Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes 1999 ·Proceedings of the National Academy of Sciences ·David A. Matthews, Peter S. Dragovich, S. E. Webber, Shella A. Fuhrman, Amy K. Patick, L S Zalman, Thomas F. Hendrickson, Robert A. Love, Thomas J. Prins, Joseph Marakovits, Ru Zhou, Jayashree Tikhe, C. E. Ford, James W. Meador, Rose Ann Ferre, Edward L. Brown, Susan L. Binford, M. A. Brothers, Dorothy M. DeLisle, Stephen T. Worland	243
8	Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P₁ Lactam Moieties as l-Glutamine Replacements 1999 ·Journal of Medicinal Chemistry ·Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Stephen E. Webber, Joseph Marakovits, Shella A. Fuhrman, Amy K. Patick, David A. Matthews, Caroline A. Lee, Clifford E. Ford, Benjamin J. Burke, Paul A. Rejto, Thomas F. Hendrickson, Tove Tuntland, Edward L. Brown, James W. Meador, Rose Ann Ferre, (unknown), Maha Kosa, Stephen T. Worland	139
9	Tripeptide Aldehyde Inhibitors of Human Rhinovirus 3C Protease: Design, Synthesis, Biological Evaluation, and Cocrystal Structure Solution of P₁ Glutamine Isosteric Replacements 1998 ·Journal of Medicinal Chemistry ·Stephen E. Webber, Kōji Okano, Thomas L. Little, Siegfried Reich, Xin Yue, Shella A. Fuhrman, David A. Matthews, Robert A. Love, Thomas F. Hendrickson, Amy K. Patick, James W. Meador, Rose Ann Ferre, Edward L. Brown, Clifford E. Ford, Susan L. Binford, Stephen T. Worland	73
10	Design, Synthesis, and Evaluation of Nonpeptidic Inhibitors of Human Rhinovirus 3C Protease 1996 ·Journal of Medicinal Chemistry ·Stephen E. Webber, Jayashree Tikhe, Stephen T. Worland, Shella A. Fuhrman, Thomas F. Hendrickson, David A. Matthews, Robert A. Love, Amy K. Patick, James W. Meador, Rose Ann Ferre, Edward L. Brown, Dorothy M. DeLisle, Clifford E. Ford, Susan L. Binford	120

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact